Roche Ups Bid For Illumina 15% To $51 A Share

Drugmaker Roche Holding raised its bid for gene sequencing company Illumina (ILMN) by 15% to $6.7 billion, or $51 a share in a contentious takeover battle that began three months ago. In a press release Thursday Illumina "recommended that its stockholders take no action at this time" in response to Roche's (RHHBY) new offering. On Feb. 7, Illumina's directors rejected Roche's $44.50 per share cash tender offer and recommended that stockholders